Address
Email address
Website
Perekliinik on kiiresti arenev, innovaatiline tervishoiuettevõte. Meie perearstikeskused asuvad Sõle ja Ülemiste Tervisemajas ning Kiili vallas.
Name
Perekliinik OÜ
Registry code
14315115
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
21.08.2017 (7)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
69202 - Bookkeeping, tax consulting 70221 - Business and other management consultancy activities 68201 - Rental and operating of own or leased real estate 86211 - Provision of general medical treatment
4 396 390 €
508 494 €
12%
1 934 €
(estimate is approximate)
516 119 €
73
Submitted
No tax arrears
99%
54%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Ingmar Lindström 16.03.1977 (47) | 100% - 2 500.00 EUR | Board member | Direct ownership | Founder |
Anna Melan 23.05.1985 (39) | - | Board member | - | |
Marge Iidel 29.06.1977 (47) | - | Board member | - |
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
MTÜ Eesti Esmatasandi Tervisekeskuste Liit 80628250 | - | - | - | Founder (without contribution) |
2019 30.06.2020 | 2020 29.06.2021 | 2021 29.06.2022 | 2022 29.06.2023 | 2023 30.06.2024 | |
---|---|---|---|---|---|
Total Revenue | 679 817 € | 1 247 758 € | 1 783 320 € | 2 462 084 € | 4 396 390 € |
Net profit (loss) for the period | 29 554 € | -3 954 € | -100 860 € | 123 803 € | 508 494 € |
Profit Margin | 4% | -0% | -6% | 5% | 12% |
Current Assets | 72 521 € | 56 123 € | 69 905 € | 168 751 € | 706 426 € |
Fixed Assets | 45 095 € | 104 543 € | 198 634 € | 191 248 € | 235 404 € |
Total Assets | 117 616 € | 160 666 € | 268 539 € | 359 999 € | 941 830 € |
Current Liabilities | 82 126 € | 155 083 € | 363 817 € | 331 474 € | 425 711 € |
Non Current Liabilities | - | - | - | - | - |
Total Liabilities | - | - | - | - | - |
Share Capital | - | - | - | - | - |
Equity | 35 490 € | 5 583 € | -95 278 € | 28 525 € | 516 119 € |
Employees | 8 | 8 | 14 | 22 | 73 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | - | 267 316.69 € | 282 171.05 € | 93 |
2023 Q4 | - | 246 191.43 € | 260 162.98 € | 86 |
2023 Q3 | - | 226 027.37 € | 235 428.08 € | 81 |
2023 Q2 | - | 168 462.11 € | 178 811.23 € | 78 |
2023 Q1 | - | 140 368.58 € | 149 065.78 € | 74 |
2022 Q4 | - | 130 017.4 € | 138 176.25 € | 55 |
2022 Q3 | - | 124 766.26 € | 132 507.09 € | 57 |
2022 Q2 | - | 112 532.96 € | 119 518.34 € | 47 |
2022 Q1 | - | 106 329.46 € | 113 005.86 € | 50 |
2021 Q4 | - | 56 352.22 € | 59 085.45 € | 50 |
2021 Q3 | - | 20 804.95 € | 21 219.76 € | 42 |
2021 Q2 | - | 16 922.79 € | 17 236.31 € | 7 |
2021 Q1 | - | 19 082.97 € | 19 440.93 € | 7 |
2020 Q4 | - | 15 622.44 € | 16 075.72 € | 7 |
2020 Q3 | - | 35 393.38 € | 29 591.1 € | 7 |
2020 Q2 | - | 20 594.58 € | 21 349.62 € | 9 |
2020 Q1 | - | 21 634.27 € | 22 788.18 € | 9 |